Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134865) titled 'Efficacy and Safety of Tepivacaine for Postoperative Analgesia and Adverse Reactions After Robot-Assisted Radical Prostatectomy' on Oct. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Weifang People's Hospital
Condition:
Prostate cancer, postoperative pain, nausea and vomiting, inflammatory response
Intervention:
Tepivacaine group:Intravenous patient-controlled analgesia with tepivacaine
Sufentanil group:Intravenous patient-controlled analgesia with sufentanil
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Tepivaca...